Difference between revisions of "MCODE FHIR IG Proposal"
Line 37: | Line 37: | ||
<!--Name and email of the primary contact for the FMG with respect to publishing for this IG?--> | <!--Name and email of the primary contact for the FMG with respect to publishing for this IG?--> | ||
+ | Publishing Facilitator (per PSS): Laura Heerman Langford (Laura dot Heermann at imail dot org) | ||
+ | Technical IG Publisher Lead: Chris Moesel (cmoesel at mitre dot org) | ||
==Contributing or Reviewing Work Groups== | ==Contributing or Reviewing Work Groups== |
Revision as of 13:15, 29 May 2019
Contents
- 1 HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE)
- 1.1 Owning work group name
- 1.2 Committee Approval Date:
- 1.3 Publishing Lead
- 1.4 Contributing or Reviewing Work Groups
- 1.5 FHIR Development Project Insight ID
- 1.6 Scope of coverage
- 1.7 Content location
- 1.8 Proposed IG realm and code
- 1.9 Maintenance Plan
- 1.10 Short Description
- 1.11 Long Description
- 1.12 Involved parties
- 1.13 Expected implementations
- 1.14 Content sources
- 1.15 Example Scenarios
- 1.16 IG Relationships
- 1.17 Timelines
- 1.18 When IG Proposal Is Complete
- 1.19 FMG Notes
HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE)
Owning work group name
Clinical Interoperability Council
Committee Approval Date:
Pending. At the last CIC meeting on May 23 2019, was agreeable to the pursuit of the FMG's approval for the mCODE FHIR IG proposal.
Publishing Lead
Publishing Facilitator (per PSS): Laura Heerman Langford (Laura dot Heermann at imail dot org) Technical IG Publisher Lead: Chris Moesel (cmoesel at mitre dot org)
Contributing or Reviewing Work Groups
- Clinical Information Modeling Initiative WG
- Clinical Genomics WG
- Public Health WG
FHIR Development Project Insight ID
1509 [1]
Scope of coverage
This IG covers elements that are key for cancer management and care according to US clinical practice, including patient demographics, details about the disease and treatment, as well as outcomes. It is intended to provide a standard for data gathered from clinician-patient interactions that take place during routine healthcare delivery, and leveraging this "real world data" for other applications, such as quality measurement, comparative effectiveness research, and shared decision making. The IG aligns with other relevant US-realm FHIR IGs, such as the Argonaut Data Query IG.
Content location
https://github.com/HL7/fhir-mCODE-ig
Proposed IG realm and code
us/mcode
Maintenance Plan
Short Description
Long Description
Involved parties
This guide was authored by the MITRE Corporation with extensive content expertise provided by the American Society for Clinical Oncology (ASCO), CancerLinQ, and with input and contributions from the HL7 community, including the Clinical Interoperability Council WG (sponsor), the Cancer Interoperability Project Group, Clinical Information Modeling Initiative WG (co-sponsor), the Clinical Genomics WG, and the Public Health WG.
Expected implementations
- Intermountain Health Care
- Partners Healthcare
- CancerLinQ
Content sources
Example Scenarios
IG Relationships
This IG depends on the Argonaut Data Query IG. There are also some inter-dependencies with the Genomics Reporting FHIR IG.
Timelines
June 27 2019
When IG Proposal Is Complete
When you have completed your proposal, please send an email to FMGcontact@HL7.org